for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Chemed Corporation

CHE

Latest Trade

444.61USD

Change

-6.02(-1.34%)

Volume

27,690

Today's Range

439.31

 - 

449.83

52 Week Range

403.00

 - 

560.00

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
450.63
Open
449.83
Volume
27,690
3M AVG Volume
2.05
Today's High
449.83
Today's Low
439.31
52 Week High
560.00
52 Week Low
403.00
Shares Out (MIL)
15.73
Market Cap (MIL)
7,089.07
Forward P/E
25.16
Dividend (Yield %)
0.32

Next Event

Q3 2021 Chemed Corp Earnings Release

Latest Developments

More

Chemed Reports Q2 Adjusted EPS $4.60

Chemed Corp's Board Authorizes An Additional $300 Mln For Stock Repurchase

Chemed Reports Q1 Adjusted Earnings Per Share $4.44

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Chemed Corporation

Chemed Corporation purchases, operates, and divests subsidiaries engaged in diverse business activities. The Company operates through two segments: the VITAS segment and Roto-Rooter segment. The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. The Company's VITAS business is operated in the state of Florida. Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. Its services are provided through a network of company-owned branches, independent contractors, and franchisees. The Company's subsidiaries include Chemed RT, Inc., Comfort Care Holdings Co., Comfort Care Holdings Co. and others.

Industry

Healthcare Facilities

Contact Info

255 E 5th St Ste 2600

CINCINNATI, OH

45202-4138

United States

+1.513.7626690

http://www.chemed.com

Executive Leadership

George J. Walsh

Independent Chairman of the Board

Kevin J. McNamara

President, Chief Executive Officer, Director

David Patrick Williams

Chief Financial Officer, Executive Vice President

Spencer S. Lee

Executive Vice President

Nicholas Michael Westfall

Executive Vice President

Key Stats

1.50 mean rating - 4 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

1.8K

2019

1.9K

2020

2.1K

2021(E)

2.1K
EPS (USD)

2018

11.930

2019

13.950

2020

18.080

2021(E)

17.913
Price To Earnings (TTM)
24.20
Price To Sales (TTM)
3.34
Price To Book (MRQ)
8.11
Price To Cash Flow (TTM)
19.57
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
29.05
Return on Equity (TTM)
22.68

Latest News

Latest News

BRIEF-Chemed Corp Q1 Revenue Rose 11.6% to $516 Million

* Q1 EARNINGS PER SHARE ESTIMATE $3.65 -- REFINITIV IBES DATA

BRIEF-Chemed Says Unit Received $80.2 Mln From The Provider Relief Fund

* CHEMED CORP - ON APRIL 10, VITAS HEALTHCARE, UNIT OF CO RECEIVED $80.2 MILLION FROM U.S. FEDERAL GOVERNMENT FROM THE PROVIDER RELIEF FUND Source text: (http://www.sec.gov/archives/edgar/data/19584/000001958420000013/0000019584-20-000013-index.htm ) Further company coverage...

BRIEF-Chemed Corporation’S Board Of Directors Authorizes An Additional $250 Million For Stock Repurchase

* CHEMED CORPORATION’S BOARD OF DIRECTORS AUTHORIZES AN ADDITIONAL $250 MILLION FOR STOCK REPURCHASE

BRIEF-Chemed Reports Q4 Adjusted Earnings Per Share $4.22

* Q4 REVENUE $522 MILLION VERSUS REFINITIV IBES ESTIMATE OF $524.2 MILLION

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up